Chordate Medical Holding AB (publ) ("Chordate") (Nasdaq First North Stockholm: CMH) will publish its interim report for Q3 2022 on Friday November 18, 2022, at 08:30 am.
A webcast teleconference with CEO Anders Weilandt will be broadcast live on Friday November 18 at 02:00 pm. The conference will be followed by a Q&A session. The presentation will be held in Swedish. It is possible to follow the conference via computer or mobile devices.
To register for the web conference, please follow this link:
Places are limited so we recommend registering well in advance to secure a place.